TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $143,739,000 | +32.8% | 1,910,170 | -52.6% | 0.03% | +52.6% |
| Q1 2022 | $108,231,000 | -43.4% | 4,030,991 | +0.5% | 0.02% | -38.7% |
| Q4 2021 | $191,261,000 | -15.5% | 4,009,654 | +17.7% | 0.03% | -18.4% |
| Q3 2021 | $226,357,000 | -15.9% | 3,407,475 | -1.2% | 0.04% | -15.6% |
| Q2 2021 | $269,155,000 | +35.4% | 3,449,809 | +64.1% | 0.04% | +28.6% |
| Q1 2021 | $198,813,000 | -27.0% | 2,101,844 | -5.9% | 0.04% | -30.0% |
| Q4 2020 | $272,182,000 | +40.9% | 2,233,745 | +1.0% | 0.05% | +25.0% |
| Q3 2020 | $193,203,000 | +31.0% | 2,211,571 | -3.2% | 0.04% | +21.2% |
| Q2 2020 | $147,515,000 | +113.1% | 2,283,872 | +47.3% | 0.03% | +83.3% |
| Q1 2020 | $69,224,000 | – | 1,550,015 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |